Followers | 171 |
Posts | 10850 |
Boards Moderated | 1 |
Alias Born | 12/08/2016 |
Monday, March 30, 2020 9:51:45 AM
“Arrayit’s microarray platform is suitable assay format for the serodiagnosis of diseases and is suitable for clinical use. The miniaturization, multiplexing and parallelism along with the ability to simultaneously detect up to 4 Ig antibodies (i.e. IgG and IgM) in a single assay have important advantages in throughput, convenience, cost and sensitivity.”
“Processing Protocol
1. Intended use
Serum based immunoassays using antigens as capture agents, designed to identify, measure and report levels of immunoglobulin proteins present in human serum, plasma or whole blood.”
https://arrayit.blogspot.com/2013/02/tech-note-miniaturized-multiplexed.html?m=1
All my posts are in my opinion only.
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM